What type of study is this?

This is a Literature Review study.

Pharmacological prevention of altitude illness, so a few words about Acetazolamide

View Full Paper

Ask AI

Bookmark

Authors

Clinical studies demonstrate acetazolamide prevents acute mountain sickness in high-altitude travelers, suggesting wider implementation is needed.

Acetazolamide significantly reduces the risk of acute mountain sickness during high-altitude ascents, enhancing acclimatization.
Using acetazolamide at 125 mg twice daily effectively prevents acute mountain sickness based on clinical studies.
The mechanism involves increased bicarbonate excretion, leading to improved blood acidity and enhanced oxygenation at high altitudes.
In life-threatening conditions like high-altitude cerebral edema and pulmonary edema, alternative treatments are primarily utilized.

Kocur et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Clinical studies demonstrate acetazolamide prevents acute mountain sickness in high-altitude travelers, suggesting wider implementation is needed.

Acetazolamide significantly reduces the risk of acute mountain sickness during high-altitude ascents, enhancing acclimatization.
Using acetazolamide at 125 mg twice daily effectively prevents acute mountain sickness based on clinical studies.
The mechanism involves increased bicarbonate excretion, leading to improved blood acidity and enhanced oxygenation at high altitudes.
In life-threatening conditions like high-altitude cerebral edema and pulmonary edema, alternative treatments are primarily utilized.

Kocur et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark